digital currency credit card Top Knowledge

Shanghai's announcement of the action plan for mergers and acquisitions of listed companies is indeed a heavy news. However, can this still retain the retail investors who were hurt by the market on Tuesday? On Tuesday, A shares opened higher and fell back, which triggered a crisis of confidence in the market to some extent. So, shall we go or stay? Let me express my personal views.Fourth, other fields also involve industrial chains such as electronic information generation, a new generation of intelligent networked vehicles and new energy vehicles, and also mention accelerating the merger of securities companies.On Tuesday, A-shares opened sharply higher and fell back, and walked out of the disgusting market, which was worse than stepping on the air. The highest point in the market was close to 3,500 points, and the result closed at 3,422.66.

The action plan can be called a heavy release in Shanghai, and I will simply classify the main contents.In the end, the A-share market has ushered in a positive trend. However, investors were like frightened birds after Tuesday's A-share surge and fall. They were already afraid of good news and didn't know whether to leave or stay. Personally, as long as the trend of A shares does not go bad, I will choose to stay.In the end, the A-share market has ushered in a positive trend. However, investors were like frightened birds after Tuesday's A-share surge and fall. They were already afraid of good news and didn't know whether to leave or stay. Personally, as long as the trend of A shares does not go bad, I will choose to stay.

First, the plan mentioned that by 2027, we will strive to land a number of representative M&A cases in key industries, form a M&A transaction scale of 300 billion yuan, and activate total assets of over 2 trillion yuan;Second, the key areas mainly involve integrated circuits, biomedicine, new materials and other industries. Make good use of the 10 billion yuan integrated circuit design industry M&A fund and set up a 10 billion yuan biomedical industry M&A fund;